Madison-based biotech firm Centrose received a six-month $224,734 grant from the National Cancer Institute to help the company determine the potential of a prospective drug compound on renal cell carcinoma, a type of kidney cancer.
Get Our Email Newsletter
The companies, people and issues shaping business in Madison and the Capital Region.
